• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.

作者信息

Campo Paloma, Soto Campos Gregorio, Moreira Ana, Quirce Santiago, Padilla-Galo Alicia, Martínez-Moragón Eva, Mardones Aizea, Dávila Ignacio

机构信息

Allergy Unit, IBIMA-Regional University Hospital of Málaga, ARADyAL, Málaga, Spain.

Pneumology and Allergy Unit, University Hospital of Jerez, Cádiz, Spain.

出版信息

Allergy. 2021 Jun;76(6):1868-1872. doi: 10.1111/all.14668. Epub 2020 Dec 31.

DOI:10.1111/all.14668
PMID:33220106
Abstract
摘要

相似文献

1
Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.在非特应性重度哮喘患者中通过奥马珠单抗治疗实现疾病控制的真实世界研究。
Allergy. 2021 Jun;76(6):1868-1872. doi: 10.1111/all.14668. Epub 2020 Dec 31.
2
[The effectiveness of target therapy in patients with severe allergic asthma].[靶向治疗在重度过敏性哮喘患者中的有效性]
Ter Arkh. 2019 Dec 15;91(12):57-62. doi: 10.26442/00403660.2019.12.000451.
3
Omalizumab: a treatment for severe asthma in real life?奥马珠单抗：现实生活中治疗重度哮喘的药物？
Rev Port Pneumol (2006). 2015 May-Jun;21(3):111-2. doi: 10.1016/j.rppnen.2015.04.002.
4
Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.不同的皮肤点刺试验致敏模式不影响重度哮喘患者对奥马珠单抗的反应。
J Investig Allergol Clin Immunol. 2017;27(6):388-391. doi: 10.18176/jiaci.0196.
5
Omalizumab could be effective in children with severe eosinophilic non-allergic asthma.奥马珠单抗可能对重度嗜酸性粒细胞性非过敏性哮喘患儿有效。
Pediatr Allergy Immunol. 2018 Feb;29(1):90-93. doi: 10.1111/pai.12813. Epub 2017 Nov 20.
6
Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.严重过敏性哮喘患儿停用奥马珠单抗：一项观察性真实世界研究。
Allergy. 2019 May;74(5):999-1003. doi: 10.1111/all.13678. Epub 2019 Jan 29.
7
[Omalizumab in children with uncontrolled asthma: a real-life study carried out in Colombia].[奥马珠单抗治疗儿童难治性哮喘：在哥伦比亚开展的一项真实世界研究]
Rev Alerg Mex. 2018 Jul-Sep;65(3):222-232. doi: 10.29262/ram.v65i3.510.
8
[Clinical experience with omalizumab in patients with severe asthma. Real-world data].[奥马珠单抗治疗重度哮喘患者的临床经验。真实世界数据]
Rev Alerg Mex. 2016 Jul-Sep;63(3):216-26. doi: 10.29262/ram.v63i3.144.
9
[The effectiveness of omalizumab in the control of severe uncontrolled asthma in Latin America. An exploratory systematic review and meta-analysis].[奥马珠单抗对拉丁美洲严重难治性哮喘的控制效果：一项探索性系统评价与荟萃分析]
Rev Alerg Mex. 2020 Jan-Mar;67(1):19-24. doi: 10.29262/ram.v67i1.701.
10
'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review.奥马珠单抗治疗成人重度变应性哮喘的真实世界疗效研究：系统评价。
Allergy. 2016 May;71(5):593-610. doi: 10.1111/all.12815. Epub 2016 Feb 25.

引用本文的文献

1
The clinical and pathological histology efficacy of biological therapy for severe asthma with a phenotype of type 2 inflammation - systematic review.2型炎症表型重度哮喘生物治疗的临床及病理组织学疗效——系统评价
Front Immunol. 2025 Apr 15;16:1531986. doi: 10.3389/fimmu.2025.1531986. eCollection 2025.
2
Personalized Medicine in Severe Asthma: From Biomarkers to Biologics.严重哮喘的个体化医学：从生物标志物到生物制剂。
Int J Mol Sci. 2023 Dec 22;25(1):182. doi: 10.3390/ijms25010182.
3
Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab.
奥马珠单抗可否作为非过敏性重症哮喘的替代疗法？奥马珠单抗的真实临床经验。
Tuberk Toraks. 2023 Mar;71(1):24-33. doi: 10.5578/tt.20239904.